Product Form

ERSORYN-40


COMPOSITION: Each pre-filled syringe contains Enoxaparin Sodium 4,000 IU anti-Xa activity (equivalent to 40 mg) in 0.4 ml water for injection.
FORMULATION: INJECTIONS
STATUS: PRESCRIPTION ONLY DRUG
DESCRIPTION: Ersoryn contains Enoxaparin, which is a low molecular weight Heparin (≈4500 dlatons) having clot dissolving and blood thinning properties and thus used in numerous micro & macro vascular complications. Ersoryn-40 is used in prophylaxis of venous thromboembolic diseases, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), prevention of thrombus formation ion during haemodialysis & treatment of unstable Angina and Myocardial infarction.
SIDE EFFECTS: Haemorrhages, Thrombocytopenia, Liver enzyme elevation and Thrombocytosis are the most commonly reported side effects.
DOSAGE/DIRECTIONS FOR USE: AS PRESCRIBED BY PHYSICIAN